https://www.selleckchem.com/products/cpi-0610.html
d for liver function monitoring. We have our protocol registered in PROSPERO. (Registration number CRD42019115549 ). We have our protocol registered in PROSPERO. (Registration number CRD42019115549 ). Angiosarcomas (AS) have poor prognosis and often metastasize to distant sites. The potential predictors of metastatic angiosarcomas (MAS) have not been extensively investigated. The main objective of this study was to identify survival predictors of MAS. Surveillance, Epidemiology, and End Results (SEER) datasets were used to identify pat
Like
Comment
Share
